Haemonetics Operating Margin 2010-2024 | HAE
Current and historical operating margin for Haemonetics (HAE) over the last 10 years. The current operating profit margin for Haemonetics as of December 31, 2024 is 15.72%.
| Haemonetics Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-12-31 | $1.37B | $0.18B | 13.17% |
| 2024-09-30 | $1.36B | $0.17B | 12.34% |
| 2024-06-30 | $1.33B | $0.15B | 11.33% |
| 2024-03-31 | $1.31B | $0.17B | 12.61% |
| 2023-12-31 | $1.27B | $0.17B | 13.40% |
| 2023-09-30 | $1.24B | $0.17B | 13.49% |
| 2023-06-30 | $1.22B | $0.18B | 14.71% |
| 2023-03-31 | $1.17B | $0.16B | 13.37% |
| 2022-12-31 | $1.13B | $0.14B | 12.41% |
| 2022-09-30 | $1.08B | $0.13B | 12.28% |
| 2022-06-30 | $1.03B | $0.11B | 10.82% |
| 2022-03-31 | $0.99B | $0.08B | 8.15% |
| 2021-12-31 | $0.95B | $0.04B | 4.30% |
| 2021-09-30 | $0.93B | $0.05B | 4.82% |
| 2021-06-30 | $0.90B | $0.08B | 8.75% |
| 2021-03-31 | $0.87B | $0.09B | 10.34% |
| 2020-12-31 | $0.88B | $0.14B | 15.52% |
| 2020-09-30 | $0.90B | $0.14B | 15.30% |
| 2020-06-30 | $0.95B | $0.13B | 13.64% |
| 2020-03-31 | $0.99B | $0.10B | 10.53% |
| 2019-12-31 | $1.00B | $0.10B | 10.21% |
| 2019-09-30 | $0.99B | $0.09B | 9.02% |
| 2019-06-30 | $0.98B | $0.07B | 6.66% |
| 2019-03-31 | $0.97B | $0.08B | 8.58% |
| 2018-12-31 | $0.95B | $0.07B | 7.67% |
| 2018-09-30 | $0.94B | $0.05B | 4.90% |
| 2018-06-30 | $0.92B | $0.04B | 4.77% |
| 2018-03-31 | $0.90B | $0.06B | 6.19% |
| 2017-12-31 | $0.90B | $-0.02B | -1.78% |
| 2017-09-30 | $0.89B | $0.00B | 0.45% |
| 2017-06-30 | $0.89B | $0.00B | 0.56% |
| 2017-03-31 | $0.89B | $-0.02B | -2.26% |
| 2016-12-31 | $0.90B | $0.03B | 3.56% |
| 2016-09-30 | $0.91B | $-0.05B | -5.52% |
| 2016-06-30 | $0.91B | $-0.06B | -6.19% |
| 2016-03-31 | $0.91B | $-0.04B | -4.85% |
| 2015-12-31 | $0.89B | $-0.03B | -2.91% |
| 2015-09-30 | $0.89B | $0.05B | 5.95% |
| 2015-06-30 | $0.90B | $0.05B | 5.12% |
| 2015-03-31 | $0.91B | $0.04B | 4.40% |
| 2014-12-31 | $0.93B | $0.04B | 4.32% |
| 2014-09-30 | $0.94B | $0.04B | 4.28% |
| 2014-06-30 | $0.94B | $0.05B | 5.41% |
| 2014-03-31 | $0.94B | $0.05B | 4.90% |
| 2013-12-31 | $0.95B | $0.05B | 5.49% |
| 2013-09-30 | $0.95B | $0.05B | 5.25% |
| 2013-06-30 | $0.94B | $0.04B | 3.96% |
| 2013-03-31 | $0.89B | $0.06B | 6.40% |
| 2012-12-31 | $0.83B | $0.06B | 7.25% |
| 2012-09-30 | $0.77B | $0.07B | 8.94% |
| 2012-06-30 | $0.73B | $0.08B | 10.64% |
| 2012-03-31 | $0.73B | $0.09B | 12.23% |
| 2011-12-31 | $0.71B | $0.10B | 13.64% |
| 2011-09-30 | $0.70B | $0.10B | 14.49% |
| 2011-06-30 | $0.69B | $0.11B | 16.20% |
| 2011-03-31 | $0.68B | $0.11B | 16.40% |
| 2010-12-31 | $0.68B | $0.09B | 12.72% |
| 2010-09-30 | $0.66B | $0.08B | 12.50% |
| 2010-06-30 | $0.65B | $0.08B | 12.39% |
| 2010-03-31 | $0.65B | $0.08B | 12.87% |
| 2009-12-31 | $0.63B | $0.10B | 15.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.166B | $1.309B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.763B | 27.35 |
| Boston Scientific (BSX) | United States | $152.152B | 38.10 |
| Stryker (SYK) | United States | $142.721B | 30.67 |
| EssilorLuxottica (ESLOY) | France | $133.556B | 0.00 |
| Medtronic (MDT) | Ireland | $108.708B | 15.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.613B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.796B | 26.03 |
| ResMed (RMD) | United States | $34.691B | 26.06 |
| GE HealthCare Technologies (GEHC) | United States | $32.200B | 15.29 |
| Agilent Technologies (A) | United States | $30.677B | 20.26 |
| Terumo (TRUMY) | Japan | $28.397B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.827B | 17.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.388B | 12.88 |
| Insulet (PODD) | United States | $17.717B | 75.76 |
| Baxter (BAX) | United States | $15.988B | 11.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.272B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.145B | 17.57 |
| Bio-Rad Laboratories (BIO) | United States | $6.837B | 23.67 |
| Prestige Consumer Healthcare (PBH) | United States | $4.024B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.362B | 28.64 |
| Envista Holdings (NVST) | United States | $2.725B | 22.03 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 18.72 |
| LeMaitre Vascular (LMAT) | United States | $2.050B | 46.77 |
| QuidelOrtho (QDEL) | United States | $1.875B | 15.70 |
| AtriCure (ATRC) | United States | $1.480B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.401B | 22.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.235B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.05 |
| BioLife Solutions (BLFS) | United States | $1.145B | 0.00 |
| Neogen (NEOG) | United States | $1.096B | 14.03 |
| InMode (INMD) | Israel | $0.981B | 8.98 |
| Phibro Animal Health (PAHC) | United States | $0.754B | 11.56 |
| Evolus (EOLS) | United States | $0.735B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.713B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.580B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.545B | 4.64 |
| Valneva SE (VALN) | France | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.479B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Surmodics (SRDX) | United States | $0.400B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.343B | 14.86 |
| Verano Holdings (VRNOF) | United States | $0.323B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 25.25 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Canopy Growth (CGC) | Canada | $0.254B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.252B | 15.10 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| Quanterix (QTRX) | United States | $0.223B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Utah Medical Products (UTMD) | United States | $0.170B | 13.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.00 |
| Organigram Global (OGI) | Canada | $0.146B | 0.00 |
| Jin Medical (ZJYL) | China | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Agape ATP (ATPC) | $0.115B | 0.00 | |
| Exagen (XGN) | United States | $0.112B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.079B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.039B | 0.00 |
| Safety Shot (SHOT) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 54.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |